Profit Margin (Quarterly) Chart

Historical Profit Margin (Quarterly) Data

View and export this data back to 2011. Start Trial.
Date Value
June 30, 2026 -107.1%
March 31, 2026 -69.17%
December 31, 2025 58.42%
September 30, 2025 -162.0%
June 30, 2025 -81.21%
March 31, 2025 -115.6%
December 31, 2024 -109.7%
September 30, 2024 -99.24%
June 30, 2024 -113.1%
March 31, 2024 -70.61%
December 31, 2023 -70.16%
September 30, 2023 -82.77%
June 30, 2023 -61.59%
March 31, 2023 -67.05%
December 31, 2022 -77.14%
September 30, 2022 -114.7%
June 30, 2022 -338.4%
March 31, 2022 -287.8%
December 31, 2021 -24.64%
September 30, 2021 -48.57%
June 30, 2021 -55.27%
March 31, 2021 -57.39%
December 31, 2020 -40.41%
September 30, 2020 -15.05%
June 30, 2020 -49.95%
Date Value
March 31, 2020 -57.86%
December 31, 2019 -39.10%
September 30, 2019 -48.64%
June 30, 2019 -48.78%
March 31, 2019 -84.57%
December 31, 2018 -45.71%
September 30, 2018 -50.93%
June 30, 2018 -61.45%
March 31, 2018 -52.47%
December 31, 2017 -37.69%
September 30, 2017 -64.43%
June 30, 2017 -70.81%
March 31, 2017 -67.37%
December 31, 2016 -70.55%
September 30, 2016 -89.18%
June 30, 2016 -66.09%
March 31, 2016 -68.56%
December 31, 2015 -41.92%
September 30, 2015 -32.36%
June 30, 2015 -53.24%
March 31, 2015 -59.60%
December 31, 2014 -32.68%
September 30, 2014 -46.53%
June 30, 2014 -45.94%
March 31, 2014 -59.92%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Illumina, Inc. 17.83%
Agilent Technologies, Inc. 19.28%
Bio-Rad Laboratories, Inc. 57.05%
Bruker Corp. -6.07%
Danaher Corp. 18.42%